• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

MannKind Corp

+ Add to Watchlist

MNKD:US

6.2500 USD 0.1400 2.19%

As of 20:10:00 ET on 04/17/2014.

Snapshot for MannKind Corp (MNKD)

Open: 6.3400 Day's Range: 6.2200 - 6.4601 Volume: 4,423,794
Previous Close: 6.3900 52wk Range: 3.7200 - 8.7000 1-Yr Rtn: +64.47%

Stock Chart for MNKD

No chart data available.
  • MNKD:US 6.2500
  • 1D
  • 1M
  • 1Y
6.3900
Interactive MNKD Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MNKD

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.6400
Est. EPS (USD) (12/2014) -0.3410
Est. PEG Ratio -
Market Cap (M USD) 2,411.57
Shares Outstanding (M) 385.85
30 Day Average Volume 14,400,233
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MNKD

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MNKD

MannKind Corporation is a biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes, cancer, inflammatory and autoimmune diseases. The Companys lead investigational product candidate is the Technosphere Insulin System.

Alfred E MannChairman/CEOHakan S EdstromPresident/COO
Matthew J Pfeffer "Matt"VP/CFO/Investor RelationsDavid B ThomsonVP/Secy/General Counsel
More Company Profile & Key Executives for MNKD

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil